0001354488-16-006184.txt : 20160212 0001354488-16-006184.hdr.sgml : 20160212 20160211175633 ACCESSION NUMBER: 0001354488-16-006184 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160212 DATE AS OF CHANGE: 20160211 EFFECTIVENESS DATE: 20160212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tribute Pharmaceuticals Canada Inc. CENTRAL INDEX KEY: 0001159019 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-31198 FILM NUMBER: 161413210 BUSINESS ADDRESS: STREET 1: 544 EGERTON ST CITY: LONDON STATE: A6 ZIP: N5W 3Z8 BUSINESS PHONE: 519-434-1540 MAIL ADDRESS: STREET 1: 544 EGERTON ST CITY: LONDON STATE: A6 ZIP: N5W 3Z8 FORMER COMPANY: FORMER CONFORMED NAME: STELLAR PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060412 FORMER COMPANY: FORMER CONFORMED NAME: STELLAR INTERNATIONAL INC DATE OF NAME CHANGE: 20010910 15-12G 1 tbuff_1512g.htm CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION tbuff_1512g.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number 000-31198

Tribute Pharmaceuticals Canada Inc.
(Exact name of registrant as specified in its charter)

151 Steeles Avenue East, Milton, Ontario, Canada L9T 1Y1
(905) 876-1118
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Shares, no par value
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 
Rule 12g-4(a)(1)
☑

 
Rule 12g-4(a)(2)
☐

 
Rule 12h-3(b)(1)(i)
☑

 
Rule 12h-3(b)(1)(ii)
☐

 
Rule 15d-6
☐

Approximate number of holders of record as of the certification or notice date: One (Common Shares, no par value)

Pursuant to the requirements of the Securities Exchange Act of 1934, Tribute Pharmaceuticals Canada Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: February 11, 2016

 
TRIBUTE PHARMACEUTICALS CANADA INC.
       
 
By:
/s/ Janice M. Clarke
  
 
Name:
 Janice M. Clarke  
 
Title:
 Vice President Finance & Administration, Treasurer & Secretary